Modified release, general properties
Modified release oral dosage forms are becoming increasingly important.
Welcome to OSMOPHARM SA
between the leaders of
Modified release products
Modified release oral dosage forms are becoming increasingly important, either to achieve the desired level of therapeutic activity required for a new drug or to extend the life cycle of an existing one.
Presentation
Osmopharm is a Swiss pharmaceutical Company. Created in 1994, it is specialised in modified release systems for oral drugs, based on the application of some of the more advanced galenic technologies.
Read: PresentationPlant
Osmopharm is located in Southern Switzerland, a few km north of Lugano and 70 km from Milan.The total covered surface, exterior warehouses comprised, is about 6.000 sqm.
Read: PlantProduct List
Our product list consist of the pharmaceuticals, pharmaceutical associations and food in the dosages and forms most required by our customers.
Open: Product List
More: Modified release, general properties
Dissolution profile behaviour
pH variation dependence and gastric protection are key concepts in our field.
Advantages and disadvantages
Some disadvantages of pharmaceutical active principles present in normal galenical forms are avoided or reduced by modified release pellets forms.
Our Customers
Osmopharm became, during the years, one of the worldwide leaders contract manufacturers in its field.
Today Osmopharm's pharmaceutical customers are over 100, most of them very prestigious.
Quality
Osmopharm SA is authorised by the Swiss National Health Authorities (Swissmedic), considered among the strictest in the world, to comply with the current GMP requisities in the manufacture of pharmaceutical products according to the Swiss regulations in force, matching customer's highest expectations.
Our Services
Osmopharm produces modified release solid oral forms and provides full services supporting its clients around the world.